CLBT

Cellebrite DI Ltd. operates in the technology sector, within the digital intelligence, forensic analysis, and data investigation subsector, with its shares traded on Nasdaq. The company’s founding is associated with Yossi Carmil and other entrepreneurs with backgrounds in telecommunications technology, digital security, and data analytics applied to investigative activities.

The company was incorporated as a privately established entity, without direct government initiative. Its initial motivations were centered on developing technological solutions capable of extracting, analyzing, and organizing digital data from mobile devices and systems, with a focus on supporting investigations, legal proceedings, and intelligence activities.

Core products and services include platforms for digital data extraction and forensic analysis, investigative intelligence solutions, advanced analytics tools, software for the collection and correlation of digital evidence, as well as support services, training, and ongoing technology updates for institutional users.

The company operates on an international scale, with a significant presence in the United States, Europe, Latin America, Asia-Pacific, the Middle East, and Africa. Its solutions are used by public security agencies, government authorities, corporate compliance departments, financial services firms, and private organizations across multiple countries.

Market drivers include the exponential growth in digital data volumes, the expanding use of mobile devices, increasing sophistication of digital crime, regulatory compliance requirements, demand for efficient investigative tools, and competition from other global providers of forensic technology and digital intelligence solutions.

Operational scale is characterized by a global base of thousands of institutional customers, recurring software licensing and services contracts, and operations distributed across multiple regions. Activities are highly intensive in research, technological development, and specialized expertise.

The operational structure is organized by product and solution lines, integrating research and development, software engineering, information security, sales, technical support, and professional services. The administrative headquarters is located in Israel, with offices, development centers, and commercial operations in multiple countries.

The primary trading ticker is CLBT, listed on Nasdaq, representing the ordinary shares of Cellebrite DI Ltd. in the U.S. equity market.

History and foundation

In its early years of operation, key challenges included the constant evolution of mobile technologies, the need to keep pace with new operating systems and devices, and the validation of its solutions with institutional clients. Early achievements included the adoption of its tools by law enforcement agencies and investigators in multiple countries.

Expansion and growth were driven by the broadening of the product portfolio, the evolution of digital analytics platforms, entry into new international markets, and diversification of applications beyond the public sector into corporate and compliance-related use cases.

Historical milestones include the strengthening of its global footprint throughout the 2010s, strategic acquisitions aimed at incorporating new digital intelligence and data analytics technologies, and the completion of its initial public offering (IPO) in 2021, with shares listed on Nasdaq.

Between 2020 and 2024, notable developments included increased demand for digital intelligence solutions, expansion of the corporate customer base, continued investment in research and development, strategic adjustments to the operating structure, ongoing evolution of technology platforms, and fluctuations in share performance influenced by macroeconomic and regulatory conditions, as well as by cycles in the technology and digital security sector.

Additional Information

The Company Cellebrite DI (United States), is listed on Nasdaq with a market value of $ 3.26 Billions, having an equity of $ 484.32 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 475.68 Millions, which generated a profit in the amount of $ 78.33 Millions.

As for its main indicators, the Company has a P/E ratio of 41.58, a P/BV ratio of 6.72 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CLBT.